Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Halocarbon is a premier manufacturer of specialty fluorochemicals, specializing in the production of high-purity inhalation anesthetics and fluorinated intermediates for the life sciences industry. Founded in 1950, the company has established itself as a global leader in fluorine chemistry, providing critical materials for pharmaceutical synthesis, medical devices, and high-performance lubricants. Their product portfolio includes widely used anesthetics such as Isoflurane and Sevoflurane, as well as a variety of inert fluids and greases. Halocarbon operates state-of-the-art manufacturing facilities that adhere to rigorous quality standards, including GMP for pharmaceutical applications. The company serves as a key partner for pharmaceutical companies requiring complex fluorination and custom chemical manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Halocarbon.